Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|May 13, 2026
Sex-Specific Patterns of Taste Dysfunction, Their Relationships with α-Synuclein Profiling, and Supervised Learning-Based Diagnosis in Parkinson's Disease (PD)Melania Melis, Fabrizio Angius, Lala Chaimae Naciri, et al.
Synapse (New York, N.Y.)|April 26, 2008
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned ratAnna R Carta, Lucia Frau, Frau Lucia, et al.
British Journal of Pharmacology|March 24, 2018
Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease modelsDaniela Lecca, Elzbieta Janda, Giovanna Mulas, et al.
Experimental Neurology|October 5, 2016
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's diseaseGiovanna Mulas, Elena Espa, Sandro Fenu, et al.
Experimental Neurology|December 13, 2023
Region-specific changes in gene expression are associated with cognitive deficits in the alpha-synuclein-induced model of Parkinson's disease: A transcriptomic profiling studyMaria Francesca Manchinu, Mauro Pala, Maria Francesca Palmas, et al.
International Journal of Molecular Sciences|November 17, 2020
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein OligomersLaura Boi, Augusta Pisanu, Maria Francesca Palmas, et al.
Journal of Neurology|July 10, 2024
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cellsAna Florencia Vega-Benedetti, Clara Porcedda, Tommaso Ercoli, et al.
Cell Death Discovery|November 28, 2025
Retinal alterations resemble brain pathology in a rat model of Parkinson's disease induced by intranigral infusion of α-synuclein oligomersChiara Burgaletto, Anna Flavia Cantone, Maria Francesca Palmas, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
A new therapeutic approach for Parkinson's disease: dual targeting of α-Synuclein aggregation and microglial function by the novel immunomodulator 3-MonothiopomalidomideMaria Francesca Palmas, Khosro Aminzadeh, Matteo Runfola, et al.
Cells|September 9, 2022
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate CortexMaria Francesca Palmas, Michela Etzi, Augusta Pisanu, et al.
Pageof 6